Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Blood|December 1, 2010
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemiaMariela Sivina, Elena Hartmann, Thomas J Kipps, et al.
Clinical Transplantation|March 8, 2017
Early conversion to belatacept after renal transplantationVinay Nair, Luz Liriano-Ward, Rebecca Kent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Multivariable model for time to first treatment in patients with chronic lymphocytic leukemiaWilliam G Wierda, Susan O'Brien, Xuemei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemiaApostolia M Tsimberidou, William G Wierda, William Plunkett, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemiaChris L Pashos, Christopher R Flowers, Neil E Kay, et al.
Clinical Transplants|May 18, 2017
Hepatitis C and Human Immunodeficiency Virus Kidney Transplantation: The Mount Sinai ExperienceVinay Nair, Rafael Khaim, Fadi El-Salem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer CenterApostolia M Tsimberidou, Sijin Wen, Susan O'Brien, et al.
The Lancet. Oncology|August 25, 2014
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 studyJan A Burger, Michael J Keating, William G Wierda, et al.
Pageof 7